Now I have all the information I need to write the consolidated review. Let me compose it.

## Summary
2-3 sentence summary of the paper's contribution.

## Strengths
- strength 1 with evidence
- strength 2 with evidence

## Weaknesses
### Fatal
### Major
### Minor
### Trivial

## Nice-to-Haves

## Removed Points

## Novel Insights

## Suggestions

## Score and Decision

Let me finalize my calibration:

**Round 1 bracket**: Between 3.5 and 7.5 (middle band). The paper is clearly not in the weak band (papers scored <3.5 have fundamental issues) and not in the strong band (papers scored >7.5 have much more thorough validation).

**Round 2 narrowing**: Looking at the middle band anchors:
- GenoAgent (4.00, Reject) - HypoGeneAgent is stronger due to its systematic Stage 1 ablation and novel formalization
- BioKGBench (4.75, Reject) - Different type of paper, but HypoGeneAgent has a more original contribution
- ZerOmics (4.67, Reject) - HypoGeneAgent seems comparable - novel method but limited validation
- BioDiscoveryAgent (6.40, Accept) - HypoGeneAgent is clearly weaker - BioDiscoveryAgent tests on 6 datasets including an unseen one

Between these, I'd place HypoGeneAgent at about 5.0. It's a genuinely interesting idea with systematic component-level validation (Stage 1) but insufficient end-to-end validation (single dataset, no ground truth, no robustness analysis). The score sits between the 4.00-4.75 reject-level papers (which have thinner contributions overall) and the 6.40 accepted paper (which has much stronger empirical validation).

Final score: **5.0**, Decision: **Reject** (the evaluation gaps are too significant for acceptance at a competitive venue, though the paper has clear potential).## Summary

HypoGeneAgent is an LLM-driven framework that generates ranked GO hypotheses for each cluster in a Perturb-seq experiment, then derives a Resolution Score (RS = w·ICS + (1−w)·(1−ICD)) that combines intra-cluster agreement and inter-cluster distinctiveness of those hypotheses. The RS is computed across a grid of Leiden resolutions to select the partition whose clusters are simultaneously internally coherent and functionally distinct, replacing the subjective manual inspection that currently dominates practice. Applied to one K562 CRISPRi Perturb-seq dataset, the RS selects resolution 0.4 (GEX level) and 0.5 (perturbation level), which the paper argues aligns with known biology better than silhouette, modularity, or standard enrichment analysis alone.

---

## Strengths

- **Novel formalization of resolution selection as annotation-consistency optimization.** The paper defines Intra-cluster Agreement (ICS), Inter-cluster Distinctiveness (ICD), and the combined Resolution Score (RSₖ = ¹⁄₃·ICSₖ + ²⁄₃·(1−ICDₖ)) in Section 3.4. This turns a traditionally heuristic, manually-driven choice (which resolution to use) into a data-driven optimization over biological coherence of the annotations — a genuinely new connection between LLM-based annotation and clustering hyperparameter selection.

- **Systematic Stage 1 benchmark comparing multiple LLMs, embeddings, prompts, and temperatures on curated GOBP sets.** Section 4.3 tests GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, and Gemini-2.5-pro across two prompt designs and multiple embedding methods (OpenAI, SapBERT, Nomic), with temperature sweeps [0,1] in 0.1 steps. The results justify the fixed configuration used downstream: GPT-o3 with the hypothesis prompt produces top-1 hypotheses whose median cosine similarity to ground-truth GO terms exceeds all competitors (Figure S1e), and its self-reported confidence aligns with semantic accuracy (Figure S3). This component-level validation strengthens confidence that the agent generates sensible annotations.

- **Two-level application (gene-expression and perturbation) with consistent findings.** The analysis runs independently on GEX clusters (marker genes) and perturbation clusters (perturbed gene sets), selecting r=0.4 and r=0.5 respectively. Both choices are consistent with the independent maxima of the ICS and ICD components (Figures 3c-d, 4c-d) and with visually well-separated UMAP embeddings. That the metric produces a defensible choice in two different feature spaces on the same data is a nontrivial sanity check.

- **Quantitative comparison against three classical criteria on the same resolution grid.** Section 4.4 reports silhouette (elbow at r=0.5–0.6), modularity (max at r=0.7), and GO enrichment analysis (RS maximum at r=0.5–0.7) on the identical resolution sweep, and shows that these traditional metrics select different resolutions than HypoGeneAgent. This side-by-side comparison on the same data provides a concrete basis for evaluating where the different methods diverge.

---

## Weaknesses

### Major

- **Evaluation on only one dataset, with no external ground-truth validation.** All results come from a single K562 CRISPRi Perturb-seq dataset (Replogle et al. 2022). The paper claims the RS "recovers known perturbation effects better" than traditional metrics, but this claim rests entirely on post-hoc reasoning about why r=0.4/0.5 is biologically sensible. There is no experiment where the RS-selected resolution is measured against an external ground truth — e.g., known cell-type labels, independent perturbation effect annotations, or a second dataset with different biology. The paper refers to itself as "a preliminary test" (abstract), but the title and conclusion present HypoGeneAgent as a general framework, and the single-dataset evaluation is insufficient to support that scope. This is the most consequential gap: without external validation, we cannot tell whether the RS is selecting a genuinely better resolution or simply reflecting properties of the LLM's output distribution on this one dataset.

- **No robustness or stochasticity analysis for the central pipeline.** The LLM (GPT-o3) outputs are generated without reported temperature for Stage 2, and no confidence intervals, repeat runs, or stability checks are provided for the Resolution Score. The Stage 1 temperature sweep was performed only on GPT-4o with the general prompt, not on GPT-o3 with the hypothesis prompt used at inference time. Because the entire resolution selection depends on the agent's outputs, it is unknown whether running the pipeline twice would select the same resolution. This is a fundamental gap for a method whose core claim is that it "selects" a resolution.

- **Resolution Score curves are nearly flat, with no statistical test supporting the selected resolution.** In Figures 3a and 4a, median resolution scores vary by only a small margin across resolutions (roughly 0.65–0.75 for most cases). The difference between r=0.4 and r=0.5 appears marginal, and no significance test is provided. The "optimal" resolution is identified by the highest median value without any formal criterion (e.g., elbow detection, gap statistic, or confidence interval). This undermines the claim that the method "selects" a resolution with certainty — the peak is ambiguous within the observed variance.

### Minor

- **The functional enrichment comparison (Section 4.4.3) is described too briefly to be fully evaluable.** The paper states it applied "similar metrics raised for HypoGeneAgent on these enrichment results" but does not specify how the GO enrichment *p*-values and term lists were converted into embeddings for the ICS/ICD metric computation. This is essential for reproducibility and for interpreting how close the agreement between the two approaches actually is.

- **The weight *w* = ¹⁄₃ is chosen by "a small grid search" with no details.** Section 3.4 mentions a grid search to select *w* but does not describe the grid, the objective function, or whether the optimal *w* is dataset-dependent. Figure S5 (referenced in text) shows that different clusters respond differently to *w*, but the analysis does not examine whether the *selected* resolution changes as *w* varies — which is the critical robustness question for the method.

- **No direct ablation testing whether the LLM adds value over a simpler annotation method for the RS.** The paper compares HypoGeneAgent against traditional clustering metrics (silhouette, modularity), but does not test a version of the same RS computed from a cheaper annotation method (e.g., standard over-representation analysis with Fisher's exact test on each cluster). Such an ablation would clarify whether the LLM is essential or whether the ICS/ICD metric framework itself is doing most of the work.

### Trivial

- None that survive filtering.

---

## Nice-to-Haves

- Testing on a second dataset (different cell line, different perturbation type, or multi-modal data) to support the claim of generality.
- Reporting LLM API costs and runtime for a full resolution sweep, as the paper mentions cost as a limitation but provides no quantification.
- A human expert evaluation of the top-1 GO hypotheses for each cluster at the selected resolution, to substantiate the claim that annotations are "accurate, unbiased."

---

## Removed Points

- **"Circular validation" claim (harsh critic point 1):** The harsh critic asserts that the functional enrichment comparison (Section 4.4.3) is circular. This is overstated. Applying the same metric framework to two independent annotation sources (LLM hypotheses and traditional enrichment) and finding that they agree on the optimal resolution is *convergent validation*, not circularity. The paper does not claim the enrichment analysis *proves* the RS correct — it shows the two methods agree, which is a reasonable sanity check. Removed because the criticism mischaracterizes what the paper does with this section.

- **"No human evaluation" (harsh critic):** Requesting a domain-expert panel to evaluate all GO hypotheses is not standard practice for a methodological paper at this stage and goes beyond what is expected. Removed as scope creep.

- **"Self-referential metrics — high ICS could mean the LLM is repetitive" (harsh critic):** This is a plausible *concern* but not a demonstrated weakness. The Stage 1 benchmark validates that GPT-o3's hypotheses match ground-truth GO terms with reasonable accuracy (AUC 0.743), mitigating the concern that the LLM is simply repeating generic themes. The criticism does not identify actual evidence of this failure in the paper's results. Removed as speculative.

- **Several formatting/style nitpicks, reproducibility nitpicks about omitted implementation details, and speculation about appendix contents.** Removed per the filtering rules.

---

## Novel Insights

None beyond the paper's own contributions. The two reviewers' critiques coalesce around the same core issue — insufficient end-to-end empirical validation despite a genuinely novel framing — but neither surfaces an insight about the method that the paper does not already articulate.

---

## Suggestions

1. **Add an external ground-truth experiment.** Obtain a labeled single-cell dataset (e.g., PBMC with known cell types, or a Perturb-seq dataset with known perturbation assignments) and ask: does the Resolution Score select a clustering that best recovers those labels? Measure with ARI, NMI, or similar. This alone would address the most serious weakness.

2. **Run the full pipeline at least 3–5 times with different random seeds** (and, if using GPT-o3, different temperature settings) and report the distribution of the selected resolution. Show that the selected resolution is stable.

3. **Replace the weight *w* ablation with a sensitivity analysis** that plots the *selected resolution* as a function of *w* ∈ [0,1]. If the selected resolution shifts with *w*, the method is not robust; if it stays constant, this strongly supports the approach.

4. **Add a simple baseline RS**: compute the same ICS/ICD metric from traditional GO enrichment *p*-values (not LLM hypotheses) and compare the selected resolution. This directly tests whether the LLM adds value or whether the metric framework itself suffices.

5. **Tone down the generalizability claims** in the title and conclusion, or add a second dataset to support them. The current evidence supports a proof-of-concept, not a general framework.

---

## Score and Decision

**Calibration:** Round 1 bracketing searched anchors in three bands: <3.5 (weak), 3.5–7.5 (middle), >7.5 (strong) on the topic of "LLM agent gene set annotation / clustering resolution / single-cell." The weak band contained papers like **scMPT** (3.40), **DrugAgent** (2.50); the middle band contained **GenoAgent** (4.00), **ZerOmics** (4.67), **LLM4GRN** (4.33), **BioKGBench** (4.75), and **BioDiscoveryAgent** (6.40); the strong band contained **CellPLM** (6.50), **GeSubNet** (8.00). The paper clearly sits in the middle band — stronger than thin-evaluation papers (GenoAgent, 4.00) but weaker than methodologically thorough accepted papers (BioDiscoveryAgent, 6.40; CellPLM, 6.50).

Round 2 narrowed within this band. The paper is more novel and better ablated than GenoAgent (4.00) and BioKGBench (4.75), but its end-to-end validation (single dataset, no ground truth, no robustness) is substantially weaker than BioDiscoveryAgent (6.40, evaluated on 6 datasets including an unseen hold-out). The paper sits near the lower-middle of the band.

**Final score: 5.0** — a genuinely interesting and well-motivated proof-of-concept that falls short of the evidentiary standard needed to support its central claims. The contribution is real, but the evaluation is incomplete.

**Anchors consulted (all rounds):**

| Anchor | Avg Score | Round | Comparison to this paper |
|--------|-----------|-------|------------------------|
| scMPT | 3.40 | R1 | Weak — less coherent contribution, more exploratory |
| DrugAgent | 2.50 | R1 | Weak — superficial multi-agent application |
| GenoAgent | 4.00 | R1, R2 | Similar domain but thinner experiments; this paper is stronger due to systematic Stage 1 ablation |
| ZerOmics | 4.67 | R2 | Comparable — novel idea, limited validation |
| LLM4GRN | 4.33 | R2 | Weaker evaluation approach |
| BioKGBench | 4.75 | R2 | Different type of contribution (benchmark); similar rigor level |
| BioDiscoveryAgent | 6.40 | R1, R2 | Stronger — evaluated on 6 datasets with unseen hold-out; this paper is weaker |
| CellPLM | 6.50 | R2 | Stronger — thorough multi-task evaluation; this paper is weaker |
| GeSubNet | 8.00 | R1 | Much stronger empirical validation |
| MaestroMotif | 7.75 | R1 | Not comparable domain |
| LLM-SR | 8.00 | R1 | Not comparable domain |

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>